Blog Large Image Simple

New summer menus available from 12th Sept.

MADISON.COM - Irish biotech company GenCell Biosystems Ltd. has opened a two-person U.S. office in Madison’s University Research Park, with plans to hire a few more people in the coming 12 months. GenCell, an analytical-instrument maker based in Limerick, employs 30 people in Ireland, where it was formed in spring 2011.

MADISON, Wis. – University Research Park today announced that GenCell Biosystems Ltd., Limerick, Ireland, will locate its U.S. subsidiary in the park’s MGE Innovation Center. The decision comes after a lengthy selection process that included some of this country’s largest metropolitan areas and most successful...

The new University of Wisconsin-Madison chancellor visited University Research Park (URP) September 19 to discuss innovations in the biotech sector. Dr. Rebecca Blank, who recently embarked on her first year as chancellor of the University of Wisconsin-Madison, chaired her first board meeting of the URP Trustees,...

Governor Scott Walker spoke on the relationship between higher education and economic development. Walker says, "Research and innovation fuel new business ventures, and investing in this partnership is essential for growing our economy."

On the 100th episode of the show, Liz Schrum catches up with Mark Bugher, the show's very first guest, to discuss his tenure as director of University Research Park and his upcoming retirement. Also on the show, Tom Still explains why new SEC regulations could adversely affect angel investments in Wisconsin and across the country; and the WisBusiness.com Stock Report for late August covers home sales and Anchor Bank.

NCD Technologies, a rising star in nano technologies, is proud to announce that their Nanocrystalline Diamond Pretreatment (NDP) an innovative and unprecedented process for applying diamond coatings to extremely small tooling, has been selected by R&D Magazine’s 100 list for technological excellence. NCD Technologies’ coatings are...

For Advanced Development of StrataGraft® Skin Tissue for Thermal Burns Stratatech Corp has been awarded a contract valued at up to $47.2 M by the U.S. Department of Health and Human Service’s Biomedical Advanced Research and Development Authority (BARDA). The contract is for the advanced clinical and manufacturing development of StrataGraft® skin tissue, its skin replacement product, as a medical countermeasure to treat patients with severe thermal burns.

Madison, WI-based Stratatech has won up to $47.2 million from the U.S. Department of Health and Human Service’s Biomedical Advanced Research and Development Authority (BARDA) to advance clinical manufacturing and development of its StrataGraft® skin tissue to treat patients with severe thermal burns.

Arecor Ltd of Cambridge, England received the “green light” and funding to pursue a research project applying Arecor’s innovative Arestat™ formulation technology to a promising flu vaccine, REDEE FLU™, developed by FluGen, Inc., of Madison, WI. The UK’s innovation agency, the Technology Strategy Board, has awarded Arecor a Proof of Concept award through its Smart programme, to engage in research and development in the strategically important area of developing a stable formulation for REDEE FLU™.

Co-working spaces are office environments where people who don’t generally work for the same company sign up to share space at a long table or a designated desk.